Meridian Bioscience Q1 Revs Drop 12 Percent

Meridian's US diagnostics sales plummeted 26 percent, while European diagnostics sales fell about 6 percent and its life science business rose 59 percent, compared to a year ago.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories